Studies have demonstrated that serum S100A12 levels were elevated in T1D patients, and such elevations were associated with inflammatory responses and diabetes in patients with stage 5 chronic kidney disease (CKD) (45, 46). This evidence concerns the gene S100A12 and chronic kidney disease.